Loading ...
ubcnewsworld
Business & Economics
4
0
Try Now
Log In
Pricing
Attogene to expand SARS-CoV-2 variants testing in the United States Attogene, a biotechnology company based in Austin, Texas, expands its product line to address the rapidly evolving testing demands within the United States, these efforts can have significant public health impact particularly as SARS-CoV-2 continues to mutate around the world. Specifically, Attogene will now distribute Novacyt's eight RUO assays, which arguably may be the most complete variant detection portfolio currently available worldwide to address the globally prevalent variants of SARS-CoV-2. Novacyt will also have available a new RUO assay to detect a novel variant originally identified in India. Attogene's focus/mission is to provide cutting edge products and services to address major environmental concerns globally. Attogene enhances health and wellness of plants, animals and the environment by offering and developing customer focused Life Science Products domestically and internationally. Attogene has additional products and services to address the growing threat from cyanotoxins associated by harmful algae blooms. Attogene.com The Novacyt Group is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialization, contract design and manufacturing. The Company's lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high- quality assays and reagents worldwide. The Group directly offers microbiology, hematology and serology products with a focus in respiratory and transplantation markets. Contact Us At: https://www.attogene .com/